1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Latvia Pharmaceuticals and Healthcare Report Q4 2015

Latvia Pharmaceuticals and Healthcare Report Q4 2015

  • August 2015
  • -
  • Business Monitor International
  • -
  • 104 pages

Includes 3 FREE quarterly updates

BMI View: The development of Latvia's market will be shaped by an increased emphasis on generic drugs;
an implication of fiscal austerity measures. As a result, despite its transparent regulatory policies and business-friendly operating environment, the Latvian pharmaceutical market will continue to remain a modest prospect for drugmakers.

Headline Expenditure Projections

- Pharmaceuticals: EUR319mn (USD428mn) in 2014 to EUR338mn (USD372mn) in 2015; +5.8% in local currency terms and -13.2% in US dollar terms. Forecast revised upwards slightly from previous quarter due to strong Q1 data.

Table Of Contents

Latvia Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 14
Pharmaceutical Market Forecast 14
Table: Pharmaceutical Sales, Historical Data And Forecasts (Latvia 2011-2019) 15
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2011-2019) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2011-2019) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Latvia 2011-2019) 19
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Latvia 2011-2019) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Latvia 2011-2019) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Latvia 2011-2019) 25
OTC Drug Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Latvia 2011-2019) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Latvia 2013-2019) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Latvia 2013-2019) 30
Key Risks To BMI's Forecast Scenario 30
Macroeconomic Forecasts 32
Economic Analysis 32
Table: GDP By Expenditure (Latvia 2012-2019) 35
Industry Risk Reward Ratings 36
Central And Eastern Europe Risk/Reward Index - Q4 2015 36
Latvia Risk/Reward Index 42
Rewards 42
Risks 42
Market Overview 44
Industry Trends And Developments 46
Epidemiology 46
Table: Leading Causes of Death, 1990-2010 46
Table: New Cases of Cancer, 2004-2010 48
Table: Cumulative Reported Cases of HIV and AIDS, 2000-2010 50
Healthcare Sector 50
Healthcare Sector Funding 51
Healthcare Provision 52
Table: Healthcare Resources (Latvia 2009-2014) 52
Table: Hospitals and Beds, 2006-2010 53
Table: Hospital Beds by Specialty, 2004-2010 53
Table: Healthcare Personnel (Latvia 2009-2014) 54
Table: Healthcare Activity (Latvia 2009-2014) 55
Research and Development 55
Biotechnology 56
Clinical Trials 58
Regulatory Development 59
Regional Collaboration 60
Intellectual Property 61
Pricing Regime 61
Reimbursement Regime 63
Competitive Landscape 65
Research-Based Industry 65
Table: Licences Issued To Companies Engaged In Pharmaceutical Manufacturing And Distribution, 2007-2011 65
Table: Medicines Consumption According To Marketing Authorisation Holders (turnover in LVL) 66
Generic Drugmakers 67
Pharmaceutical Distribution 67
Table: Wholesale Mark-Up Scheme For Reimbursable Pharmaceuticals, 2008 68
Table: Wholesalers Market Share, 2010 (%) 70
Pharmaceutical Retail Sector 70
Table: Pharmacy Mark-Up Scheme For Reimbursable Pharmaceuticals, 2008 71
Table: Licences Issued To Pharmacies 72
Company Profile 74
GlaxoSmithKline 74
Grindeks 77
Merck and Co 81
Novartis 83
Olainfarm 85
Pfizer 89
Sanofi 91
Demographic Forecast 93
Table: Population Headline Indicators (Latvia 1990-2025) 94
Table: Key Population Ratios (Latvia 1990-2025) 94
Table: Urban/Rural Population and Life Expectancy (Latvia 1990-2025) 95
Table: Population By Age Group (Latvia 1990-2025) 95
Table: Population By Age Group % (Latvia 1990-2025) 96
Glossary 98
Methodology 100
Pharmaceutical Expenditure Forecast Model 100
Healthcare Expenditure Forecast Model 100
Notes On Methodology 101
Risk/Reward Index Methodology 102
Index Overview 103
Table: Pharmaceutical Risk/Reward Index Indicators 103
Indicator Weightings 104

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...

North America Syringes and Needles Market Outlook to 2021

North America Syringes and Needles Market Outlook to 2021

  • $ 5 995
  • Industry report
  • April 2016
  • by Global Data

North America Syringes and Needles Market Outlook to 2021 Summary GlobalData’s new report, "North America Syringes and Needles Market Outlook to 2021", provides key market data on the North America Syringes ...

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Pharmaceutical Market - 2016; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 5 750
  • Industry report
  • April 2016
  • by Feedback Business Consulting

This report provides an insight into the Indian Pharmaceutical current market scenario, structure and practices. In depth market scenario includes; - Current market size estimates, including domestic market, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.